New scoring system for ICU patients considering inflammation and nutrition
Comparison of the New Score (APACHE-INf), Including Inflammatory and Nutritional Parameters, With APACHE-II in the Prognosis of Patients Admitted to ICU
This study is testing a new scoring system for ICU patients that takes into account inflammation and nutrition to see if it can better predict their outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Bursa City Hospital Government |
| Locations | 1 site (Nilüfer, Bursa) |
| Trial ID | NCT05955547 on ClinicalTrials.gov |
What this trial studies
This observational study aims to develop a new prognostic scoring system, APACHE-INf, for patients admitted to intensive care units (ICUs) by incorporating inflammatory parameters and nutritional status into the assessment. Current scoring systems, like APACHE-II, primarily focus on organ dysfunction and overlook these critical factors that significantly impact patient outcomes. By evaluating the role of inflammation and nutritional deficiencies, the study seeks to enhance the accuracy of prognosis predictions for ICU patients. The research will involve collecting data from patients over 18 years old admitted to the ICU at Bursa City Hospital and its affiliated institutions.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who are admitted to the ICU.
Not a fit: Patients under 18 years old or those with incomplete data will not benefit from this study.
Why it matters
Potential benefit: If successful, this new scoring system could lead to improved patient outcomes by enabling more accurate prognostic assessments and timely interventions.
How similar studies have performed: While existing studies have focused on inflammation and nutrition separately, this approach of integrating both into a prognostic scoring system is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ICU admission * Age over 18 Exclusion Criteria: * Incomplete data * Age under 18
Where this trial is running
Nilüfer, Bursa
- University of Health Sciences, Bursa Sehir Training & Research Hospital — Nilüfer, Bursa, Turkey (Recruiting)
Study contacts
- Principal investigator: Nizameddin Koca, MD — University of Health Sciences, Bursa Sehir Training & Research Hospital
- Study coordinator: Nizameddin Koca, MD
- Email: nkoca@yahoo.com
- Phone: 05052324063
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.